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The challenge of performing a time-resolved comprehensive analysis of molecular systems has led to the
quest to optimize extraction methods. When the size of a biological sample is limited, there is demand
for the simultaneous extraction of molecules representing the four areas of “omics”: genomics, tran-
scriptomics, proteomics, and metabolomics. Here we optimized a protocol for the simultaneous
extraction of DNA, RNA, proteins, and metabolites and compared it with two existing protocols. Our
optimization comprised the addition of a methanol/chloroform metabolite puriﬁcation before the sep-
aration of DNA/RNA and proteins. Extracted DNA, RNA, proteins, and metabolites were quantitatively
and/or qualitatively analyzed. Of the three methods, only the newly developed protocol yielded all
biomolecule classes of adequate quantity and quality.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Systems biology as an interdisciplinary ﬁeld is focused on the
understanding of cellular systems at the molecular level. Various
“omic” technologies are used to gain insight into the complex in-
teractions of biomolecules within biological systems on a
comprehensive scale [1]. Technical developments in genomics,
transcriptomics, proteomics, and metabolomics enable monitoring
and quantiﬁcation of biomolecules in a high-throughput manner
[2e4]. The integration of omic technologies is difﬁcult when the
same sample is not used for comprehensive molecular analysis.
Hence, it is necessary to develop methods for the simultaneous
extraction and effective recovery of the target biomolecules DNA,
RNA, proteins, and metabolites. So far, protocols exist for isolating
three of the four molecule classes [5,6] or all four from prokaryotes
[7], but there is currently no reliable method for the simultaneous
extraction of the four molecule classes from eukaryotic cells.e; SDS, sodium dodecyl sul-
, polymerase chain reaction;
, liquid chromatography; MS/
phy; MRM, multiple reaction
, molecular weight.
r Inc. This is an open access articleThe goal of this study was to optimize a method for the simul-
taneous extraction of DNA, RNA, proteins, and metabolites and
compare it with two existing, well-established methods that were
designed to extract only one class of molecules speciﬁcally. We
applied it to the analysis of Jurkat T cells as a model for native
human T cells [8], and in order to rule out cell-line-speciﬁc effects
we also tested the process by analyzing murine hepatocyte cells.
Our method (here method C) was based on our good experience
with the simultaneous puriﬁcation of RNA, DNA, and proteins
starting with a phenol/chloroform-based extraction. To also purify
metabolites, we added a methanol/chloroform-based extraction of
metabolites prior to the phenol/chloroform-based steps.
Our method was compared with that (here method A) reported
by Weckwerth and coworkers describing the concomitant extrac-
tion of RNA, proteins, and metabolites from plant material [9]. We
subsequently probed the quality of the remaining DNA fractionated
by this protocol. In addition, a thirdmethod (here method B), based
on the manufacturer's protocol of the TRI Reagent for RNA, DNA,
and protein isolation with an additional step included to extract
metabolites, was tested (http://www.sigma-aldrich.com) for the
two different cell lines.
The suitability of the extraction methods for the biomolecule
classes was evaluated by assessing the quantity and quality of DNAunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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detection of hydrophilic metabolites of the central carbon and ni-
trogen metabolism. Because the protocols tested resulted in
differing extraction efﬁcacies for the omic technologies, this study
will aid in selecting themost suitablemethod for a speciﬁc research
question.
Materials and methods
Cell culture
Human Jurkat T cells (clone E6-1, ATCC, Germany) were cultured
in RPMI-1640 medium containing 10% (v/v) fetal calf serum, 1% (v/
v) streptomycin (100 mg/ml)/penicillin (100 U/ml), and 1% (v/v) L-
glutamine in a CO2 incubator (MCO-18AIC, Sanyo Electric, Japan) at
37 C and an atmosphere of 5% CO2. The cells were cultured at a
density of 1  106 cells/ml. Murine Hepa 1c1c7 cells (clone CRL-
2026, ATCC, Germany) were cultured in Dulbecco's modiﬁed Ea-
gle's medium (DMEM) containing 10% (v/v) fetal calf serum, 1% (v/
v) streptomycin (100 mg/ml)/penicillin (100 U/ml), and 1% (v/v) L-
glutamine in a CO2 incubator at a density of 1  104 cells/cm2. Cell
viability and cell numbers were determined using trypan blue and a
Neubauer-improved chamber (Optic Labor, Germany). Aliquots of
1 107 cells werewashed twicewith 1 phosphate-buffered saline
(PBS) and centrifuged at 300 g for 5 min. The obtained cell pellets
were resuspended in 50 ml of PBS and processed via method A, B, or
C or well-established protocols. Each method was conducted in
triplicate.
Method A
The pelleted Jurkat T or Hepa cells were processed as described
byWeckwerth and coworkers [9] with modiﬁcation as follows. The
RNA buffer phase was directly subjected to acetic acid/ethanol
precipitation of nucleic acids. An extraction buffer of 0.05 M Tris
(pH 7.6), 0.5% sodium dodecyl sulfate (SDS), and 1% b-mercaptoe-
thanol was used. The precipitated nucleic acids were resuspended
in 100 ml of water and proteins in 300 ml of 1 M urea and 0.05 M Tris
(pH 7.6) for further analysis. DNA and RNA samples were stored
at 80 C, and metabolite and protein samples were stored
at 20 C, until further analysis.
Method B
To a pellet of Jurkat T or Hepa cells, 50 ml of 1 PBS and 1 ml of
TRI Reagent (SigmaeAldrich Chemie, Steinheim, Germany) were
added and processed according to the manufacturer's instructions
with modiﬁcations as follows. After TRI Reagent/chloroform
extraction, RNA was precipitated by the addition of 0.5 ml ice-cold
isopropanol and incubation for 10 min at room temperature, fol-
lowed by centrifugation for 10 min at 4 C and 4000 g. The super-
natant containing the metabolites was subsequently transferred to
a fresh tube and dried under vacuum. DNA was resuspended in
300 ml of 8 mMNaOH, RNA in 50 ml of H2O, and proteins in 100 ml of
1% SDS.
Method C
An aliquot of Jurkat Tor Hepa cells was dissolved in 1ml of a 45%
(v/v) methanol/5% (v/v) chloroform solution and incubated for
30 min at 4 C while rotating. The cell suspension was centrifuged
at 500 g for 10min, and themetabolite-containing supernatant was
transferred to a new tube and dried under vacuum.
The remaining pellet was resuspended in 100 ml of 1 PBS.
Approximately 1 ml of H2O saturated phenol was added forseparation of RNA, DNA, and proteins, and the sample was incu-
bated for 5 min at 4 C while rotating. For phase separation, 200 ml
of chloroform was added, and the sample was incubated for 5 min
at room temperature (RT), followed by centrifugation at 12,000 g
for 15 min at 4 C. After phase separation, the upper RNA-
containing phase was mixed with 500 ml of ice-cold isopropanol,
incubated for 10min at RT, and centrifuged for 20min at 12,000 g at
4 C. The obtained RNA pellet was washed using 75% (v/v) ethanol,
air dried for 10e15 min at RT, and resuspended in 50 ml of H20. To
the remaining middle and lower phases of the phenol chloroform
extraction, 500 ml of DNA extraction buffer (4 M guanidinium
thiocyanate, 50 mM sodium citrate, and 1 M Tris base) was added.
The solution was mixed by inversion, incubated for 30 min at RT,
and centrifuged for 20 min at 12,000 g at 4 C. For DNA precipita-
tion, 500 ml of ice-cold isopropanol containing 20 mg/ml glycogen
was added to the upper and middle phases. After incubation for
10 min at RT, the solution was centrifuged for 20 min at 12,000 g at
4 C. The DNA-containing pellet was washed twice by adding 1.5 ml
of 75% (v/v) ethanol and centrifuged for 10min at 7500 g. The pellet
was dried at RT for 10 min and resuspended in 100 ml of TE buffer.
For protein extraction, 1.5 ml of ice-cold isopropanol was added
to the remaining lower phase, and the sample was incubated
overnight at 20 C to precipitate the proteins. The solution was
then centrifuged for 15 min at 12,000 g at 4 C. The protein pellet
was washed by the addition of 1 ml 0.3 M guanidinium chloride in
90% (v/v) ethanol, incubation for 10 min at RT, and subsequent
centrifugation for 5 min at 7500 g at 4 C. The pellet was washed a
second time with 1 ml of ethanol. The protein pellet was dried for
20e30min at RTand dissolved in 100 ml of 6M urea/2M thiourea in
100 mM ammonium bicarbonate buffer.
Well-established control methods
For isolation of DNA from Jurkat and Hepa cells, the genomic
DNA (gDNA) isolation kit from Zymo Research (Orange, CA, USA)
was used following the manufacturer's instructions. The DNA was
eluted from columns in 100 ml of TE buffer.
RNA from Jurkat and Hepa cells was extracted using the Qiagen
RNeasy Mini Kit (Hilden, Germany). For elution of RNA from the
columns, 50 ml of H2O was used.
Extraction of Jurkat and Hepa cell proteins was performed by
lysing the cells with 6 M urea/2 M thiourea in 100 mM ammonium
bicarbonate for 5 min at RT, followed by ultrasonication for 30 s.
Samples were subsequently centrifuged for 5 min at 12,000 g at
4 C, and the protein-containing supernatant was transferred to a
new tube.
For extraction of metabolites, a hot water method (method GS1)
and a boiling ethanol method (method GS2) were conducted as
described by Canelas and coworkers [10].
DNA quality control
The quantity of isolated DNAwas determined for all methods by
an ND spectrophotometer (Thermo Scientiﬁc, Germany), and the
quality was tested by 0.8% (w/v) agarose gel electrophoresis. A 16.7-
ml sample of DNA extracted via method A and 600-ng samples of
DNA extracted via methods B and C were each mixed with 6 DNA
Loading Dye (Thermo Scientiﬁc). Genomic DNA showing a distinct
signal in the high molecular range of approximately 20 kB was
considered to be intact or only partially degraded at the end of the
extraction procedure.
For evaluation of DNA quality, Jurkat DNA samples were further
analyzed by polymerase chain reaction (PCR) using the DNAQuality
Ready Kit (Bio-Budget Technologies, Krefeld, Germany) following
the manufacturer's instructions. PCR batches were calculated on a
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GS) and 2.4 ml of 1:10 diluted gDNA extracted via method A were
inserted into the gDNA quality control PCR. PCR products were
separated on a 1.8% (w/v) agarose gel. The ampliﬁcation of six PCR
fragments of 100, 200, 300, 400, 500 (control fragment), and 600 bp
of gDNA indicates that the corresponding DNAwas not found to be
degraded after the extraction process. Fewer than six amplicons
showed DNA with any degree of degradation.
RNA quality control
The quantity of extracted RNA was determined by an ND spec-
trophotometer (Thermo Scientiﬁc), and its quality was assessed by
analyzing 10 ml (method A) or 1.5 mg (methods B, C, and GS) on 1.8%
(w/v) agarose gel. Each sample was mixed with 2 RNA Loading
Dye (Thermo Scientiﬁc), applied to a gel, and run for 45 min at
100 V. RNA samples showing the characteristic ribosomal RNA
bands of 5070 and 1869 bp with no background noise were
considered to be intact, or only slightly degraded, at the end of the
extraction procedure.
Next, 1 ml of 1:3 diluted RNA (method A) and 50 ng of extracted
RNA (methods B, C, and GS) were applied to an RNA Nano Chip
(Agilent Technologies, Waldbronn, Germany) and run on an Agilent
2100 Bioanalyzer following the manufacturer's instructions. RNA
with RNA integrity number (RIN) values greater than 8 were
considered to be intact and usable for quantitative PCR (qPCR) and
other follow-up experiments.
Protein quality control
The quantity of isolated proteins was determined using Quick
StarteBradford Dye Reagent according to the manufacturer's in-
structions (Bio-Rad Laboratories, Germany). The quality of extrac-
ted proteins was evaluated by separation of 30 mg proteins by
SDSePAGE (polyacrylamide gel electrophoresis), followed by Coo-
massie Brilliant Blue staining according to the method described in
Ref. [11]. The protein lane of each sample was cut into four slices,
and each slice (~7.5 mg of protein) was digested with 150 ng of
trypsin. Generated peptides were extracted from the gel pieces and
analyzed via liquid chromatographyetandem mass spectrometry
(LCeMS/MS) using a nano-HPLC (high-performance liquid chro-
matography) system (nanoAcquity, Waters, Milford, MA, USA)
coupled to an LTQ Orbitrap XL mass spectrometer (Thermo Fisher
Scientiﬁc, San Jose, CA, USA), and liquid chromatography was car-
ried out using a 110-min gradient with 0.1% formic acid in 100%
water (solvent A) and 100% acetonitrile (solvent B). After sample
injection into a trapping column (nanoAcquity UPLC [ultra-
performance liquid chromatography] column, C18,
180 mm  20 mm, 5 mm particles, Waters), peptides were separated
on a C18 column (nanoAcquity UPLC column, C18, 7 mm  150 mm,
1.7 mm particles, Waters) using the following gradient of solvent B
in solvent A: starting at 2%, reaching 6% after 5 min, 20% after
45min, 30% after 70min, 40% after 75min, 85% after 80min, and 2%
after 95 min and washing for 15 min at 2% with a ﬂow rate of
300 nl/min.
Full-scan MS spectra (from 300 to 2000 m/z, R ¼ 60,000) were
acquired in a positive ion mode in the LTQeVelos Orbitrap. Up to
the 10 most intense ions per scanwith a charge greater than 2 were
fragmented and analyzed in the linear trap. Peptide ions exceeding
an intensity of 3000 were chosen for collision-induced dissociation
within the linear ion trap (isolation width ¼ 4 m/z, normalized
collision energy ¼ 35%, activation time ¼ 30 ms, activation
q ¼ 0.25). For MS/MS acquisition, a dynamic exclusion of 2 minwas
applied. For a more detailed description, see Baumann and co-
workers [12]. Data analysis of the MS results was performed usingMaxQuant (version 1.3.0.5) including the following search param-
eters: ion mass tolerance of 0.5 Da and parent ion tolerance of
20 ppm. Carbamidomethylation of cysteine was speciﬁed as a ﬁxed
modiﬁcation. Oxidation of methionine and acetylation of the pro-
tein N terminus were speciﬁed as variable modiﬁcations. Max-
Quant was set up to search a reverse concatenated database of all
human proteins annotated in the SwissProt database (version 10/
01/2013) assuming the digestion enzyme trypsin. Only proteins
found in two of three replicates were considered to be unambig-
uously identiﬁed.
Metabolite analysis
For ion chromatographyetandem mass spectrometry (ICeMS/
MS)-based analysis of metabolites, extracts were dissolved in a total
volume of 25 ml and analyzed on an ICS-5000 (Thermo Fisher Sci-
entiﬁc, Dreieich, Germany) coupled to an API 5500 QTrap (AB Sciex)
as described elsewhere [13]. Separation was obtained on an IonPac
AS11-HC column (2  250 mm, Thermo Fisher Scientiﬁc) with an
increasing potassium hydroxide gradient. MS analysis was per-
formed in multiple reaction monitoring (MRM) mode using nega-
tive electrospray ionization and included organic acids,
carbohydrates, and nucleotides involved in central metabolite
pathways. Metabolites were considered to be detectable above a
signal-to-noise ratio of 3 within a retention time window of
0.5 min.
Results and discussion
Time and material required for performing the three extraction
methods
The optimized protocols used to separate the target bio-
molecules from a single sample of Jurkat T cells or Hepa cells is
shown in Fig. 1; the others are shown in the online supplementary
material (Figs. S1 and S2).
Method A was based on a study describing the simultaneous
extraction of RNA, proteins, and metabolites from plant material
[9]. Metabolites are extracted by a methanol/chloroform treatment,
leaving a pellet that can be used for further protein, DNA, and RNA
extraction using phenol-based phase separation [9]. Notably, this
protocol does not produce separation of RNA from DNA.
Method Bwas based on the TRI Reagent manufacturer's protocol
(SigmaeAldrich) for RNA, DNA, and protein isolation. The cell pellet
was resuspended in TRI Reagent, enabling the successive isolation
of RNA, DNA, and proteins. Metabolites were obtained from the
supernatant remaining after precipitation of RNA, and proteins
were obtained by vacuum drying of the respective fraction.
Method C involved a novel process of methanol/chloroform-
based extraction of metabolites followed by RNA, DNA, and pro-
tein extraction using a phenol/chloroform extraction.
The three methods required similar time andmaterials. Protocol
A could be performed in 4 h plus an additional hour the following
day for centrifugation and ethanol washing to remove remaining
phenol from proteins isopropanol-precipitated overnight. Using
method B, it was possible to extract all four biomolecule classes in
4 h because proteins were not precipitated overnight. Protocol C
could be carried out in 3 h plus an additional 1.5 h the following day
for pelleting and phenol depletion of proteins after overnight pre-
cipitation. Each method contained a step of phenol/chloroform-
based phase partitioning, enabling the separation of nucleic acids
from proteins. Protocols A and C involved methanol/chloroform-
based metabolite extraction steps prior to DNA, RNA, and protein
isolation. Considering only time and material required, method B
would be the protocol of choice, the disadvantage being that only
Fig.1. Schematic of extraction procedure. The newly developed process for the extraction of four biomolecule classes from a single set of cells is depicted. *DEB, DNA extraction
buffer (method C; see Supplemental ﬁgure).
F. Vorreiter et al. / Analytical Biochemistry 508 (2016) 25e3328three of the four molecule classesdnamely DNA, RNA, and pro-
teinsdcan be isolated.
DNA isolation: enrichment strategies, purity, and yield
DNA samples from method A also contained RNA when sepa-
rated on an agarose gel because no further partitioning of the
nucleic acid classes was conducted. In addition, DNA extracted via
method A was found to be partially degraded at the end of the
puriﬁcation on the agarose gel. With methods B and C and the well-
established method (GS), the extracted DNA did not show RNAcontent as judged by agarose gel or signs of degradation in Jurkat or
Hepa cells (data not shown). For assessing quality and integrity, the
extracted Jurkat DNA was further analyzed by PCR using the DNA
Quality Ready Kit (Bio-Budget Technologies). PCR products were
analyzed by agarose gel electrophoresis. DNA extracted via method
A showed weaker signal intensities for the expected PCR products
than that derived via methods B, C, and GS (Fig. 2A). The kit is
designed for human samples, and application to murine Hepa cell
DNA was unsuccessful. Methods B and C can be used for the
extraction of gDNA, showing acceptable DNA integrity and purity
for further applications.
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Fig.2. Quality assessment of three of the four molecule classes isolated. (A) PCR for
gDNA quality determination. Here 48 ng of gDNA (methods B and C) and 1 ml of 1:10
diluted gDNA extracted via method A were inserted into gDNA quality control PCR. (B)
Results of Agilent 2100 Bioanalyzer measurements. Here 50 ng of RNA (methods B and
C) and 1 ml of 1:3 diluted RNA extracted via method A were applied to an RNA
nanochip. (C) Separation of 30 mg protein extracted using the three methods in a 12%
SDSepolyacrylamide gel, followed by Coomassie Brilliant Blue G250 staining. Each lane
was cut into four parts and subjected to tryptic digestion followed by LCeMS/MS.
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classes are summarized in Table 1. The gDNA content determined
via Nanodrop for method A cannot be considered as accurate
because both RNA and DNAwere present in the sample. In addition,
the DNA obtained by method B was difﬁcult to dissolve andremained viscous, making the determined quantity questionable.
Nevertheless, the volume of DNA isolated with the tested methods
was more than sufﬁcient for standard genomic applications such as
PCR and DNA sequencing, which need approximately 60 ng and
1 mg of gDNA, respectively.
RNA isolation: enrichment strategies, integrity, and yield
When using method A, the RNA was mixed with DNA and
partially degraded, as shown by the 1.8% agarose gel. Formethods B,
C, and GS, no RNA degradation was detected (data not shown), and
Bioanalyzer measurements conﬁrmed its integrity, with RIN values
ranging from 8.4 to 10, whereas values were 3.3e3.8 for method A
(Fig. 2B). For downstream transcriptomic analyses, including qPCR
applications, it is generally recommended to use RNA samples with
a minimum RIN of 7 [14]. Methods B, C, and GS are suitable for the
extraction of high-quality RNA that can be used in downstream
applications.
We isolated approximately 28.7/79.6 mg (Jurkat/Hepa) of RNA
from 1  107 cells using method A (Nanodrop/containing DNA),
78.9/380.7 mg using method B, 13.8/161.6 mg using method C, and
14.4/7.7 mg with GS (Table 1).
From Jurkat cells, we isolated approximately 28.7 mg of RNA
using method A (Nanodrop), 78.9 mg using method B, 13.8 mg using
method C, and 14.4 mg with GS. Hepa cells yielded approximately
79.6 mg with method A, 380.7 mg with method B, 161.6 mg with
method C, and 7.7 mg with GS (Table 1).
Methods B, C, and GS yielded a quantity of RNA sufﬁcient for
further analyses such as RNA sequencing (requiring 500 ng of
DNase-treated RNA) and reverse transcription followed by qPCR
(recommended 5 mg of DNase-treated RNA). With method A, RNA
and DNA were combined.
Protein isolation: enrichment strategies, purity, physicochemical
bias, and yield
As with RNA and DNA, the yield of extracted proteins varied for
the three protocols and the well-established method (GS). From
Jurkat cells, method A produced 147.7 mg, method B 65.3 mg,
method C 125.8 mg, and thewell-establishedmethod 519.3 mg. Yield
from Hepa cells was 465.4 mg for method A, 168.2 mg for method B,
323.2 mg for method C, and 961.3 mg for the well-established
method (Table 1).
Resuspension of proteins using 1% SDS (method B) was difﬁcult
or impossible, and a large portion of the pellet remained undis-
solved. This was also reported by Sim~oes and coworkers [15], who
found that further modiﬁcations of the protocol, including urea/
SDS solubilization and sonication, increased protein yield.
An equal volume of protein (30 mg) extracted by the three
methods and GS were precipitated, resuspended in sample buffer,
and separated in a 12% SDSepolyacrylamide gel (Fig. 2C). The
peptides obtained by in-gel digestion were extracted and analyzed
using LCeMS/MS. Coomassie-stained SDSepolyacrylamide gel
indicated low molecular weight proteins (<35 kDa) to be under-
represented using method A compared with extraction via
methods B and C (Fig. 2C). The tendency of proteins less than
25 kDa to be underrepresented in global proteome studies can be
associated with factors such as lower efﬁcacy of precipitation [16],
loss during destaining [17], and a scarcity of readily detectable
tryptic peptides [18].
Visual comparison of band patterns in SDSegel lanes corre-
sponding to extracts derived from methods A, B, and C revealed
distinct similarities. High molecular weight proteins showed
similar abundance in extracts of the three methods. For more
comprehensive insight into the proteome data, the proteins/
Table 1
Yield, quality, and sensitivity of detection of the four classes of biomolecules extracted from 1  107 Jurkat T cells and Hepa 1c1c7 cells by the three methods.
   Method 
A
Method GS 
GS 
B
Method 
C
μg 
isolated
9.9 35.8 174.9 18.8
quality *** * * ***
μg 
isolated
14.4 28.7 78.9 13.8
quality *** * *** ***
μg 
isolated
519.3 147.7 65.3 125.8
quality *** *** *** ***
μg 
isolated
30/29 35 8 37
quality *** ** * ***
Method 
A
Method 
B
Method 
C
μg 
isolated
17.1 99.5 153.6 45.2
quality *** * * ***
μg 
isolated
7.7 79.6 380.7 161.6
quality *** * *** ***
μg 
isolated
961.3 465.4 168.2 323.2
quality *** *** *** ***
μg 
isolated
31/30 23 8 37
quality *** ** * ***
Jurkat E6-1
Hepa 1c1c7
DNA
RNA
Protein
Metabolite
DNA
RNA
Protein
Metabolite
F. Vorreiter et al. / Analytical Biochemistry 508 (2016) 25e3330peptides identiﬁed in Jurkat T cells and Hepa cells by methods A, B,
and C were analyzed in greater detail (Fig. 3). The detection overlap
of the three methods was greater for Hepa cells than for Jurkat T
cells (Fig. 3A). Mass spectrum analysis yielded similar numbers of
identiﬁed proteins and demonstrated a broad overlap of the three
protocols and the GS in Jurkat T cells (method A: 1091 identiﬁed
proteins; method B: 1271; method C: 870) (Fig. 3C). The three
methods show an overlap of 792 identiﬁcations. Methods A and B
show an overlap of 23þ 792 hits, methods B and C show an overlap
of 34þ 792 , and methods A and C show an overlap of 231þ792. In
addition, 35 unique proteins were extracted and identiﬁed using
method A, 221 using method B, and 21 using method C.
Numbers and overlap of identiﬁed proteins using pellets of Hepa
1c1c7 cells are also shown in Fig. 2.
A critical factor in extraction protocols is systematic bias due to
physicochemical properties of the target molecules. This is not
supposed to be crucial for molecules like RNA and DNA whose
building blocks are rather homogeneous but highly relevant when
the molecules differ substantially, as is the case with proteins.
Therefore, we analyzed the physicochemical parameters of the
detected proteins from Jurkat and Hepa cells: hydrophobicity (by
GRAVY [grand average of hydropathy] score), isoelectric point (pI),
and molecular weight (MW) (Fig. 3B). The GRAVY scores calculated
according to Kyte and Doolittle [19] showed a Gaussian-type dis-
tribution pattern in the range of 2 to approximately þ0.5 with amaximum of0.5 and a frequency of 120e160. The pattern showed
high similarity of extracted proteins to the GRAVY distribution of
the annotated human proteome (UniProt 09/2013), but the GRAVY
range of þ0.2 toþ1 was underrepresented, indicating that strongly
hydrophobic proteins were not readily targeted using the three
methods. For strongly hydrophobic proteins, we recommend the
use of dedicated protocols. Another possible reason for the rela-
tively low recovery of hydrophobic proteins might be the precipi-
tation approach used. A study of urine samples of limited
complexity revealed that hydrophobic precipitation favored the
enrichment of acidic and hydrophilic proteins and showed a
negative bias against hydrophobic proteins [20]. Because the
methods compared here used hydrophobic precipitation, it is not
surprising that they show a similar bias. There were differences in
the proteomic proﬁles obtained by the three methods; hence, the
comparison of proteomic analyses based on different extraction
protocols is problematic.
The pI proﬁles of identiﬁed proteins showed a similar distribu-
tion across extraction methods. They displayed two well-separated
peaks: one at pI 4.0 to 7.0, with a maximum of 5.0 and a frequency
of 140, and a second at pI 7.0 to 12.0, with a maximum of 9.0
and a frequency of 80. Compared with the pI distribution of the
annotated human proteome, the pI 8 to 10 protein fraction was
underrepresented in the protein samples extracted via methods A,
B, and C.
Fig.3. Overlap and physicochemical properties of identiﬁed proteins. Proteins were identiﬁed by LCeMS/MS after tryptic digestion of 30 mg protein extracted by the three methods
from 1  107 Jurkat T cells and 1  107 Hepa 1c1c7 cells. (A) Number and overlap of proteins identiﬁed. (B) GRAVY, MW, and pI distribution of the corresponding proteome (human or
murine) and of identiﬁed proteins. (C) Proportion of identiﬁed proteins isolated by the “gold standard” protein extraction method that was also found with methods A, B, and C.
F. Vorreiter et al. / Analytical Biochemistry 508 (2016) 25e3332The identiﬁed proteins showed a similar MWdistribution across
methods, with a maximum frequency of 350e400 at 35e40 kDa
and a gradual decrease in the range of 75e200 kDa, with few
proteins detected above 200 kDa. The three MW distribution pro-
ﬁles correlatedwell with the hypothetical distribution proﬁle of the
annotated human proteome.
Metabolite extraction: enrichment strategies, purity, and yield
As a benchmark for the efﬁcacy of metabolite extraction, we
used an established targeted multianalyte (>40) approach [13]
because we were primarily interested in the primary products of
carbon and nitrogenmetabolism. Method B was not suitable for theJurkat T-
Glycolysis A B
Glucose 1.0 0.
Glucose 6-phosphate 1.0 0.
Glucose 1-phosphate 1.0 0.
Fructose 6-phosphate 1.0 0.
Fructose 1,6-bisphosphate 1.0 1.
2-Phosphoglyceric acid 1.0 1.
Pentose phosphate pathway 
Gluconate 6-phosphate 1.0 0.
Ribulose/Ribose 5-phosphate 1.0 0.
Xylulose 5-phosphate 0.0 0.
Sedoheptulose 7-phosphate 0.0 0.
Erytrose 4-phosphate 1.0 0.
Ribose 1,5-bisphosphate 0.0 0.
Glycerol 3-phosphate 1.0 1.
Pyruvate metabolism
Phosphoenolpyruvate 1.0 1.
Pyruvate 1.0 0.
Lactate 1.0 0.
Acetate 1.0 0.
Formate 1.0 0.
TCA cycle
Citrate 1.0 0.
Aconitate 1.0 0.
Isocitrate 1.0 1.
Ketoglutaric acid 1.0 0.
Succinate 1.0 0.
Fumarate 1.0 0.
Malate 1.0 0.
Nucleotides
Adenosine monophosphate 1.0 0.
Adenosine diphosphate 1.0 1.
Adenosine triphosphate 1.0 1.
Nicotinamide adenine dinucleotide 1.0 0.
Nicotinamide adenine dinucleotide phosphate 1.0 0.
Uridine diphosphate 1.0 0.
Uridine triphosphate 1.0 1.
Organic acids
Maleate 1.0 0.
Acetate 1.0 0.
Formate 1.0 0.
Glycolate 0.0 0.
Tartrate 1.0 0.
Glyoxalate 0.0 0.
Aspartate 1.0 0.
Glutamate 0.0 0.
Ala, Asp and Glu metabolism
Succinic semialdehyde 1.0 0.
Fig.4. Metabolites determined by ICeMS/MS extracted by the three methods. Green boxes
detection. (For interpretation of the references to color in this ﬁgure legend, the reader isextraction of metabolites by ICeMS/MS analysis because the de-
tergents of the TRI Reagent used have a negative inﬂuence on the
detectability of target analytes. In the analysis of samples from
method B, the MRM chromatograms were characterized by a high
level of background noise and a longer reequilibration time for
consecutive runs.
Method A produced 35 detectablemetabolites in Jurkat cells and
23 in Hepa cells, method C produced 37 in both cell types, GS1
produced 30 in Jurkat cells and 31 in Hepa cells, and GS2 produced
29 in Jurkat cells and 30 in Hepa cells (Fig. 4). All metabolites
detected with method A were present in the MRM chromatograms
of method C. The intensities were higher in method C by a factor of
5e15, indicating clearly higher recovery of the target analytes bycells Hepatocytes
C GS1 GS2 A B C GS1 GS2
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 0.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 0.0 1.0 1.0 1.0 1.0 0.0 1.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 0.0 0.0 0.0 1.0 1.0 0.0
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0 1.0 0.0 0.0 0.0 0.0 1.0 1.0 1.0
0 1.0 1.0 0.0 0.0 0.0 1.0 1.0 0.0
0 1.0 1.0 0.0 0.0 0.0 1.0 1.0 0.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0
0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 0.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 0.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 0.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 0.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 0.0 1.0
0 1.0 0.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0
0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0 1.0 1.0 1.0 1.0 0.0 1.0 1.0 1.0
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0 1.0 1.0 1.0 0.0 0.0 1.0 1.0 1.0
indicate potential quantitative measurements, and red boxes indicate no metabolite
referred to the Web version of this article.)
F. Vorreiter et al. / Analytical Biochemistry 508 (2016) 25e33 33method A. At least six metabolites detected with the identical
instrumental setup in earlier studies [12,21] were not found after
extraction method A in this study.
Conclusions
The comparison of threemethods for simultaneous extraction of
DNA, RNA, proteins, and metabolites from Jurkat T cells and hepa-
tocytes showed adequate agreement between the cell lines.
Method A was found to be suitable for metabolite and protein
extraction, but not for speciﬁc extraction of RNA and DNA, and
produced slightly lower detection of metabolites than method C.
Method B provided high-quality RNA and protein samples but
nearly unresolvable DNA and protein. Our attempts to add
metabolite extraction tomethod B failed, as assessed by ICeMS/MS.
Only method C provided DNA, RNA, protein, and metabolite sam-
ples that passed all quality benchmarks in both tested cell lines.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ab.2016.05.011.
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